Clean Science & Technology Ltd
Incorporated in 2003, Clean Science and Technology Ltd is one of the leading chemical manufacturers globally. It manufactures functionally critical specialty chemicals such as Performance Chemicals (MEHQ, BHA, and AP), Pharmaceutical Intermediates (Guaiacol and DCC), and FMCG Chemicals (4-MAP and Anisole). [1]
- Market Cap ₹ 13,809 Cr.
- Current Price ₹ 1,300
- High / Low ₹ 1,622 / 1,277
- Stock P/E 54.4
- Book Value ₹ 103
- Dividend Yield 0.38 %
- ROCE 45.4 %
- ROE 34.0 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 44.4% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 36.7%
- Company has been maintaining a healthy dividend payout of 55.5%
Cons
- Stock is trading at 12.6 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|
140 | 191 | 241 | 393 | 419 | 512 | 685 | 936 | 781 | |
92 | 118 | 168 | 256 | 234 | 253 | 385 | 533 | 437 | |
Operating Profit | 48 | 72 | 73 | 137 | 186 | 260 | 300 | 403 | 344 |
OPM % | 34% | 38% | 30% | 35% | 44% | 51% | 44% | 43% | 44% |
2 | 4 | 5 | 11 | 11 | 25 | 30 | 39 | 37 | |
Interest | 3 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 |
Depreciation | 6 | 6 | 8 | 11 | 14 | 17 | 25 | 36 | 43 |
Profit before tax | 41 | 70 | 70 | 137 | 182 | 267 | 305 | 405 | 338 |
Tax % | 34% | 33% | 30% | 28% | 23% | 26% | 25% | 25% | |
27 | 47 | 49 | 98 | 140 | 198 | 229 | 304 | 254 | |
EPS in Rs | 192.41 | 330.79 | 343.72 | 690.82 | 1,051.82 | 18.68 | 21.52 | 28.57 | 23.89 |
Dividend Payout % | 13% | 12% | 12% | 15% | 2% | 134% | 15% | 18% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 31% |
3 Years: | 31% |
TTM: | -15% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 44% |
3 Years: | 30% |
TTM: | -11% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -9% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 38% |
3 Years: | 37% |
Last Year: | 34% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 1 | 1 | 1 | 1 | 1 | 11 | 11 | 11 | 11 |
Reserves | 99 | 143 | 186 | 271 | 341 | 529 | 758 | 1,008 | 1,088 |
12 | 0 | 1 | 3 | 3 | 0 | 0 | 1 | 1 | |
27 | 35 | 48 | 53 | 85 | 120 | 156 | 139 | 124 | |
Total Liabilities | 139 | 179 | 236 | 328 | 430 | 660 | 925 | 1,159 | 1,223 |
64 | 77 | 101 | 126 | 166 | 186 | 296 | 427 | 418 | |
CWIP | -0 | 2 | 1 | 4 | 3 | 55 | 44 | 4 | 2 |
Investments | 1 | 32 | 18 | 76 | 134 | 233 | 247 | 428 | 544 |
75 | 68 | 115 | 122 | 127 | 187 | 338 | 300 | 259 | |
Total Assets | 139 | 179 | 236 | 328 | 430 | 660 | 925 | 1,159 | 1,223 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|
69 | 45 | 85 | 160 | 193 | 127 | 299 | ||
-52 | -17 | -94 | -106 | -186 | -124 | -245 | ||
-15 | -5 | -11 | -55 | -6 | -0 | -55 | ||
Net Cash Flow | 2 | 23 | -20 | -1 | 1 | 4 | -0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 68 | 41 | 60 | 55 | 61 | 53 | 82 | 58 |
Inventory Days | 246 | 165 | 93 | 79 | 98 | 156 | 143 | 122 |
Days Payable | 79 | 73 | 85 | 48 | 101 | 180 | 166 | 90 |
Cash Conversion Cycle | 235 | 134 | 69 | 87 | 58 | 29 | 59 | 89 |
Working Capital Days | 131 | 64 | 61 | 65 | 35 | 32 | 90 | 66 |
ROCE % | 55% | 42% | 59% | 59% | 61% | 47% | 45% |
Documents
Announcements
- Board Meeting Intimation for Consideration Of Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2024 And Recommendation Of Final Dividend For The Financial Year Ended 31St March, 2024 20 Apr
-
Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015.
16 Apr - Listing Regulations, 2015 please find enclosed certificate dated 15th April, 2024 received from J B Bhave & Co., Practicing Company Secretaries for the financial year …
- Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI (LODR) Regulations, 2015. 15 Apr
-
Announcement under Regulation 30 (LODR)-Acquisition
5 Apr - Investment in Clean Fino-Chem Limited -wholly owned subsidiary.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
5 Apr - Confirmation Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
Concalls
-
Feb 2024Transcript PPT REC
-
Jan 2024TranscriptNotesPPTREC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT REC
-
May 2023Transcript PPT REC
-
Feb 2023Transcript PPT REC
-
Oct 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
Product Segments & Revenue split FY22
Performance chemicals (70%): 4 key products are MEHQ, BHA, AP and TBHQ. [1]